Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New mechanism involved in the anxiolytic effect of flesinoxan?

Dec. 4, 1997

Abecarnil reverses benzodiazepine resistance in mice

Dec. 4, 1997

NeoTherapeutics' cognition enhancer in preclinical testing

Dec. 4, 1997

Novo Nordisk licenses tiagabine to Sanofi

Dec. 3, 1997

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

CoCensys/Acea reveal new AMPA receptor antagonists/positive modulators

Dec. 3, 1997

FDA approves ANDA for generic clozapine

Dec. 3, 1997

Anticonvulsant activity demonstrated for adenosine kinase inhibitor

Dec. 3, 1997

Behavioral effects of neurosteroid elucidated in nonhuman primate model

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...